Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

ABCL - 1584

Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

Muhammad Sarfraz Khan

Poster Presenter: Muhammad Sarfraz Khan

Thumbnail for Persistent Gender, Racial, and Urban-Rural Disparities in Mantle Cell Lymphoma Mortality in the United States, 1999-2024: Evidence of Stalled Progress in the Targeted Therapy Era

MCL - 167

Persistent Gender, Racial, and Urban-Rural Disparities in Mantle Cell Lymphoma Mortality in the United States, 1999-2024: Evidence of Stalled Progress in the Targeted Therapy Era

Tapan Giri

Poster Presenter: Tapan Giri

Previous 1...85 86 87 88 89 90 91...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States

MM - 1145

Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States

Baqir Jafry

Poster Presenter: Baqir Jafry

Thumbnail for Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

MPN - 696

Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

ABCL - 1574

Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

Imran Khan

Poster Presenter: Imran Khan

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

ABCL - 1058

Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

Sinya Okamura

Poster Presenter: Sinya Okamura

Thumbnail for Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in ? Light-Chain Amyloidosis

MM - 218

Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in ? Light-Chain Amyloidosis

Giada Bianchi

Poster Presenter: Giada Bianchi

$Thumbnail for Phase 3 Results From the EPCORE FL-1 Trial of Epcoritamab (E) With Lenalidomide and Rituximab (R2) versus R2 for Relapsed or Refractory Follicular Lymphoma (R/R FL)$

IBCL - 1332

Phase 3 Results From the EPCORE FL-1 Trial of Epcoritamab (E) With Lenalidomide and Rituximab (R2) versus R2 for Relapsed or Refractory Follicular Lymphoma (R/R FL)

Bradley D. Hunter*

Poster Presenter: Bradley D. Hunter*

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors